SE502323C2 - Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi - Google Patents
Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemiInfo
- Publication number
- SE502323C2 SE502323C2 SE8703308A SE8703308A SE502323C2 SE 502323 C2 SE502323 C2 SE 502323C2 SE 8703308 A SE8703308 A SE 8703308A SE 8703308 A SE8703308 A SE 8703308A SE 502323 C2 SE502323 C2 SE 502323C2
- Authority
- SE
- Sweden
- Prior art keywords
- treatment
- compound
- hydroxyethyl
- cerebral ischemia
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19879686 | 1986-08-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8703308D0 SE8703308D0 (sv) | 1987-08-26 |
| SE8703308L SE8703308L (sv) | 1988-02-28 |
| SE502323C2 true SE502323C2 (sv) | 1995-10-02 |
Family
ID=16397046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8703308A SE502323C2 (sv) | 1986-08-27 | 1987-08-26 | Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4870090A (xx) |
| JP (1) | JPH07121863B2 (xx) |
| KR (1) | KR950002151B1 (xx) |
| AU (1) | AU603375B2 (xx) |
| BE (1) | BE1003959A5 (xx) |
| CA (1) | CA1302888C (xx) |
| CH (1) | CH672069A5 (xx) |
| DE (1) | DE3728499A1 (xx) |
| DK (1) | DK171392B1 (xx) |
| FI (1) | FI873727A (xx) |
| FR (1) | FR2605222B1 (xx) |
| GB (1) | GB2195532B (xx) |
| HK (1) | HK64993A (xx) |
| IE (1) | IE60601B1 (xx) |
| IT (1) | IT1211477B (xx) |
| LU (1) | LU86973A1 (xx) |
| NL (1) | NL8701994A (xx) |
| NO (1) | NO873571L (xx) |
| NZ (1) | NZ221564A (xx) |
| SE (1) | SE502323C2 (xx) |
| SG (1) | SG52393G (xx) |
| ZA (1) | ZA876401B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736529A (en) * | 1996-03-22 | 1998-04-07 | Neurocal International Inc. | Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration |
| US6329349B1 (en) * | 1997-10-23 | 2001-12-11 | Trustees Of The University Of Pennsylvania | Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents |
| WO2000067754A1 (en) | 1999-05-12 | 2000-11-16 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| CN107773545A (zh) | 2016-08-29 | 2018-03-09 | 烟台益诺依生物医药科技有限公司 | 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1562962A (en) * | 1976-04-02 | 1980-03-19 | Chugai Pharmaceutical Co Ltd | Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same |
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| EP0223811A1 (en) * | 1985-05-22 | 1987-06-03 | Beecham Group Plc | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease |
| US4696934A (en) * | 1986-01-10 | 1987-09-29 | Warner-Lambert Company | Method for using nifedipine for treating stroke |
| WO1987005508A1 (en) * | 1986-03-14 | 1987-09-24 | Medical College Of Wisconsin Research Foundation, | Method of treatment and prevention of cerebral vasospasms |
-
1987
- 1987-08-19 IE IE221887A patent/IE60601B1/en not_active IP Right Cessation
- 1987-08-21 IT IT8767725A patent/IT1211477B/it active
- 1987-08-21 AU AU77311/87A patent/AU603375B2/en not_active Ceased
- 1987-08-24 NO NO873571A patent/NO873571L/no unknown
- 1987-08-24 US US07/089,044 patent/US4870090A/en not_active Expired - Lifetime
- 1987-08-25 NZ NZ221564A patent/NZ221564A/xx unknown
- 1987-08-25 DK DK441987A patent/DK171392B1/da not_active IP Right Cessation
- 1987-08-26 FR FR878711957A patent/FR2605222B1/fr not_active Expired - Fee Related
- 1987-08-26 KR KR1019870009346A patent/KR950002151B1/ko not_active IP Right Cessation
- 1987-08-26 SE SE8703308A patent/SE502323C2/sv not_active IP Right Cessation
- 1987-08-26 BE BE8700948A patent/BE1003959A5/fr not_active IP Right Cessation
- 1987-08-26 LU LU86973A patent/LU86973A1/fr unknown
- 1987-08-26 DE DE19873728499 patent/DE3728499A1/de not_active Withdrawn
- 1987-08-26 NL NL8701994A patent/NL8701994A/nl active Search and Examination
- 1987-08-26 CA CA000545418A patent/CA1302888C/en not_active Expired - Fee Related
- 1987-08-27 GB GB8720219A patent/GB2195532B/en not_active Expired - Fee Related
- 1987-08-27 FI FI873727A patent/FI873727A/fi not_active Application Discontinuation
- 1987-08-27 ZA ZA876401A patent/ZA876401B/xx unknown
- 1987-08-27 JP JP62213808A patent/JPH07121863B2/ja not_active Expired - Fee Related
- 1987-08-27 CH CH3298/87A patent/CH672069A5/de not_active IP Right Cessation
-
1993
- 1993-04-23 SG SG52393A patent/SG52393G/en unknown
- 1993-07-08 HK HK649/93A patent/HK64993A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE60601B1 (en) | 1994-07-27 |
| IT8767725A0 (it) | 1987-08-21 |
| NO873571D0 (no) | 1987-08-24 |
| ZA876401B (en) | 1988-04-27 |
| GB2195532A (en) | 1988-04-13 |
| BE1003959A5 (fr) | 1992-07-22 |
| FI873727A0 (fi) | 1987-08-27 |
| DE3728499A1 (de) | 1988-03-03 |
| CA1302888C (en) | 1992-06-09 |
| KR950002151B1 (ko) | 1995-03-14 |
| AU603375B2 (en) | 1990-11-15 |
| SE8703308D0 (sv) | 1987-08-26 |
| DK171392B1 (da) | 1996-10-14 |
| NZ221564A (en) | 1999-08-30 |
| US4870090A (en) | 1989-09-26 |
| DK441987D0 (da) | 1987-08-25 |
| NO873571L (no) | 1988-02-29 |
| NL8701994A (nl) | 1988-03-16 |
| FR2605222B1 (fr) | 1991-02-22 |
| FI873727A (fi) | 1988-02-28 |
| IE872218L (en) | 1988-02-27 |
| SE8703308L (sv) | 1988-02-28 |
| KR880002525A (ko) | 1988-05-09 |
| IT1211477B (it) | 1989-11-03 |
| CH672069A5 (xx) | 1989-10-31 |
| SG52393G (en) | 1993-08-06 |
| JPS63152317A (ja) | 1988-06-24 |
| GB2195532B (en) | 1990-05-23 |
| LU86973A1 (fr) | 1987-12-16 |
| HK64993A (en) | 1993-07-16 |
| JPH07121863B2 (ja) | 1995-12-25 |
| GB8720219D0 (en) | 1987-10-07 |
| AU7731187A (en) | 1988-03-03 |
| FR2605222A1 (fr) | 1988-04-22 |
| DK441987A (da) | 1988-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104662007B (zh) | 胱硫醚‑γ‑裂合酶(CSE)抑制剂 | |
| EP2892518B1 (en) | Compositions for treating parkinson's disease | |
| RU2221563C2 (ru) | Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона | |
| DE3650733T2 (de) | Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe | |
| CN109748881A (zh) | 胱硫醚-γ-裂合酶(CSE)抑制剂 | |
| JP2001503737A (ja) | 糖尿病の発生を防止するためのシブトラミン類似体の利用 | |
| JPS6084251A (ja) | 鎮痛用新規化合物および組成物 | |
| EP0658110B1 (en) | Use of norastemizole for the treatment of allergic rhinitis | |
| BR112019023101B1 (pt) | Composições farmacêuticas e métodos de tratamento para doenças cardiovasculares | |
| JP5116207B2 (ja) | 神経保護、抗うつおよび抗虚血活性を有する新規アダマンタン誘導体、およびその製造法 | |
| JPH0232015A (ja) | 薬剤の製造のためのモノ置換セレン有機化合物の使用、ならびにそれから製造される薬剤およびその薬剤の製造方法 | |
| SE502323C2 (sv) | Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi | |
| US4131678A (en) | Urapidil/furosemide compounds, compositions and use | |
| DE69307702T2 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| US4067983A (en) | Pharmaceutical compositions and methods | |
| JPS6081127A (ja) | 食欲抑制剤 | |
| JPH02193922A (ja) | 細胞保護用組成物 | |
| US4645770A (en) | Agent for treating Parkinson's disease or Parkinsonism | |
| JP4032437B2 (ja) | 痴呆治療剤 | |
| JP3061445B2 (ja) | 血管拡張剤 | |
| JPH04208223A (ja) | 肝臓疾患治療剤 | |
| JPH03232870A (ja) | チオアミド化合物 | |
| JPH0228113A (ja) | 高尿酸血症改善・治療剤 | |
| EA002676B1 (ru) | Применение 2-амино-6-трифторметоксибензотиазола для профилактики или лечения дисфункции мозжечка | |
| EP0317105A2 (en) | Phenylalanine derivative and its uses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |